Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04705337Phase 4Terminated
Levosimendan In Ambulatory Heart Failure Patients
Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure With Reduced Ejection Fraction+1 more
PrincipalinvestigatorStart date: 2021-12-15

Research Network

Collaboration Network

8 collaborators·28 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marek Gierlotka, Prof. MD

University of Opole

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Grzegorz Grześk, Prof. MD

Nicolaus Copernicus University in Toruń

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Janina Stępińska, Prof. MD

Cardinal Stefan Wyszyński Institute of Cardiology

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Jarosław Kasprzak, Prof. MD

Medical University of Łódź

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Jacek Kubica, Prof. MD

Nicolaus Copernicus University in Toruń

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Ewa Straburzyńska-Migaj, Prof. MD

Poznan University of Medical Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Agnieszka Tycińska, Prof. MD

Medical University of Bialystok

Moderately Similar
1 trials

Shared therapeutic areas:

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more

Worked with same sponsors:

Azienda Ospedaliera dei ColliJohn Paul II Hospital, Krakow+7 more
Collaborated on 1 trial
Similarity Score44%

Kenneth McDonald, Professor

St Vincent's Private Hospitale Ltd, Dublin, Ireland

Related
1 trials

Shared therapeutic areas:

Heart Failure, Systolic
Similarity Score8%

Henry Krum, Professor

Monash University

Related
1 trials

Shared therapeutic areas:

Heart Failure, Systolic
Similarity Score8%

Marco Metra, MD

UOC Cardiologia, Spedali Civili di Brescia

Related
1 trials

Shared therapeutic areas:

Heart Failure, Systolic
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04705337Phase 4PrincipalInvestigator

Levosimendan In Ambulatory Heart Failure Patients

Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure With Reduced Ejection Fraction+1 more
Terminated

All 1 trials loaded